Sort by
Refine Your Search
-
Country
-
Employer
- University of Texas at Tyler
- The Ohio State University
- University of North Carolina at Chapel Hill
- Massachusetts Institute of Technology
- University of Colorado
- University of Minnesota
- Duke University
- Indiana University
- Loyola University
- Texas A&M University
- University of Kentucky
- University of Manchester
- Aarhus University
- Baylor College of Medicine
- Brigham and Women's Hospital - Department of Dermatology
- CNRS
- Columbia Center for Translational Immunoogy
- EPFL
- Eli Lilly and Company
- FAPESP - São Paulo Research Foundation
- Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences (formerly Institute of Genetics and Animal Biotechnology PAS)
- Institute of Macromolecular Chemistry CAS
- Johns Hopkins University
- Lunds universitet
- Massachusetts Institute of Technology (MIT)
- Northeastern University
- Plymouth University
- Saint Louis University
- Singapore-MIT Alliance for Research and Technology
- Stanford University
- The University of Iowa
- UNIVERSITY OF VIENNA
- University of California Irvine
- University of California, Los Angeles
- University of Illinois
- University of Limerick
- University of Maryland, Baltimore
- University of Miami
- University of Nebraska Medical Center
- University of New Hampshire
- University of North Texas at Dallas
- University of Oregon
- University of Oxford
- University of Pittsburgh
- University of Utah
- University of Vienna
- Wayne State University
- Zintellect
- 38 more »
- « less
-
Field
-
heterologous expression. The expressed antibodies will then be assessed for affinity to snake venom toxins by surface plasmon resonance and ELISA, in order to compare their effectiveness with
-
killing assays, colony immunoblot. Performs mammalian cell culture (both primary cells and cell lines), macrophage killing assays, opsonophagocytic assays, ELISAs, ELISpot, C1q deposition, western blot, etc
-
lab techniques: classical diagnostic parasitology techniques, microscopy, parasite culture, in vitro assays, DNA and RNA extraction, PCR, RTPCR, qPCR, qRT-PCR, digital PCR, and ELISA. Experience with
-
in other clinical trials. You will be responsible for undertaking and developing assays (MSD, ELISpot, ELISA, and other functional assays) for evaluation of malaria vaccines in human clinical trials
-
proof-of-concept study using protein A resin (as a model resin), 2 IgG product streams produced by a platform CHO cell lines and advanced analytical methodology (including LC-MS, ELISA and CE-SDS
-
, ELISA, coagulation assays as well as carry out data analysis. The candidate’s research experience, technical skills, and relevance to the PI’s research will be used in determining the title and
-
scientific presentations and perform other work-related duties, as assigned. Run assays such as molecular cloning, Western Blots, qPCR, Flow Cytometry, ELISA, biomedical imaging, protein purifications
-
. Experimental approaches will include primary human cell culture, ELISA, ELISPOT, protein assays, RNA-seq, single-cell genomic approaches, and functional cell-based assays. The applicant will also be involved in
-
or other related fields; and be skilled in cell culture, microfluidic fabrication, modeling organ systems, characterization assays such as PCR, immunostaining, flow cytometry, ELISA etc. PREFERRED
-
three-dimensional hydrogel systems, or related methods. • Experience with multiplexed proteomics, Luminex assays, ELISA, or related protein analysis platforms. • Experience performing histological